23andMe Can Now Test Your DNA For Breast Cancer Risk
23andMe recently received FDA approval to inform customers of its popular mail-in DNA tests about their risk for breast cancer, the Atlantic reported. 23andMe is the first company to get federal approval for a direct-to-consumer genetic cancer risk test. The FDA sanctioned 23andMe’s request to tell customers whether they have mutations on the genes BRCA-1…